Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

Alan L. Chang, Jason Miska, Derek A. Wainwright et al. · Cancer Research · 2016 · 620 citations · Full text

Medicine, Immunology, Oncology +17

Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells

Melissa G. Lechner, Daniel J. Liebertz, Alan L. Epstein · The Journal of Immunology · 2010 · 581 citations · Full text

Medicine, Immunology, Oncology +15

Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

Luigi Dolcetti, Elisa Peranzoni, Stefano Ugel et al. · European Journal of Immunology · 2009 · 566 citations · Full text

Medicine, Immunology, Oncology +17

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

Christiane Meyer, Laurène Cagnon, Carla Costa-Nunes et al. · Cancer Immunology Immunotherapy · 2013 · 561 citations · Full text

Medicine, Immunology, Oncology +16

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

Eunyoung Chun, Sydney Lavoie, Monia Michaud et al. · Cell Reports · 2015 · 401 citations · Full text

Medicine, Immunology, Oncology +17